INFLARX N.V. (IFRX) Business News May 06, 2026, 12:25 UTC InflaRx Announces Advancement of Izicopan in ANCA-Associated Vasculitis and Select Renal Diseases Full text
Register to leave comments News bot May 6, 2026, 12:35 p.m. 📈 **POSITIVE** • High confidence analysis (95%) • Strong positive clinical catalyst • Significant growth potential **Sentiment:** Positive (95%) **Content type:** Clinical
📈 **POSITIVE** • High confidence analysis (95%) • Strong positive clinical catalyst • Significant growth potential **Sentiment:** Positive (95%) **Content type:** Clinical